All diseases

Disease Atlas / Disease detail

Cardiomyopathy

This is an educational draft that concisely summarizes the definition, causes, symptoms, diagnosis, management, and interpretation of evidence for cardiomyopathy, a group of diseases affecting the heart muscle.

cardiomyopathy · Cardiomyopathies · cardiomyopathy

MONDO:0004994Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · 05ad430dea58

Disease category
Cardiomyopathy is a group of diseases characterized by abnormalities in the structure or function of the heart muscle, which may become enlarged, thickened, or stiff.
Core mechanism
Hypertension, infections, and other cardiac or systemic diseases may be involved; some types are familial, and in some cases, the cause remains unidentified.
Main causes/related factors
Changes in the thickness, elasticity, contractility, or relaxation of the heart muscle may impair the heart's ability to receive or pump blood.
Representative patterns
Typical clinical manifestations include heart failure, abnormal heart rhythms, and valvular problems; in severe cases, these may be associated with cardiac arrest.
Individual differences
The risk and prognosis vary depending on the type of cardiomyopathy, cause, family history, comorbidities, age, and cardiac function.
Diagnosis
Although some individuals are asymptomatic, symptoms such as dyspnea, fatigue, decreased exercise tolerance, edema, palpitations, chest pain, or syncope may occur, and the clinical course varies among individuals.
Management
Diagnosis is made by comprehensively integrating medical history, family history, and physical examination with ECG, echocardiography, imaging tests, and necessary blood and genetic tests.
Treatment/Research Status
A single test result alone cannot definitively determine the type, cause, or future risk; differentiation from other cardiac diseases and clinical context are important.
Read Evidence
Management is carried out by combining medications, procedures/surgeries, and lifestyle adjustments while evaluating cardiac function, symptoms, arrhythmia, and the risk of complications.
Key Precautions
Treatment varies depending on the cause and type, and the current goal is to reduce symptoms and the risk of complications and to manage cardiac function and quality of life.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a Glance

Cardiomyopathy is a group of diseases characterized by abnormalities in the structure or function of the heart muscle, which may become enlarged, thickened, or stiff.

Typical clinical manifestations include heart failure, abnormal heart rhythms, and valvular problems; in severe cases, these may be associated with cardiac arrest.

How the disease works

Hypertension, infections, and other cardiac or systemic diseases may be involved; some types are familial, and in some cases, the cause remains unidentified.

Changes in the thickness, elasticity, contractility, or relaxation of the heart muscle may impair the heart's ability to receive or pump blood.

Variations in presentation among individuals

The risk and prognosis vary depending on the type of cardiomyopathy, cause, family history, comorbidities, age, and cardiac function.

The broad framework of diagnosis and management

Although some individuals are asymptomatic, symptoms such as dyspnea, fatigue, decreased exercise tolerance, edema, palpitations, chest pain, or syncope may occur, and the clinical course varies among individuals.

Diagnosis is made by comprehensively integrating medical history, family history, and physical examination with ECG, echocardiography, imaging tests, and necessary blood and genetic tests.

Current status of treatment

A single test result alone cannot definitively determine the type, cause, or future risk; differentiation from other cardiac diseases and clinical context are important.

Management is carried out by combining medications, procedures/surgeries, and lifestyle adjustments while evaluating cardiac function, symptoms, arrhythmia, and the risk of complications.

Treatment varies depending on the cause and type, and the current goal is to reduce symptoms and the risk of complications and to manage cardiac function and quality of life.

How to read clinical trials

In follow-up observations, changes in symptoms, ECG, and cardiac function must be continuously monitored, and the existence of a registered study does not, in itself, imply efficacy, approval, or standard of care.

Points to verify during clinical consultations

In clinical practice, it is important to verify symptoms and onset time, presence of syncope or palpitations, family history of heart disease or sudden death, current medications and comorbidities, tests performed, and follow-up plans.

Medical Guidance

This material is for educational purposes and is not intended as a guide for individual diagnosis or treatment. Consult with medical professionals regarding the interpretation of symptoms or test results.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.